Compare H1B visa sponsorship data between Institute for Cancer Research and Mastech. See how they stack up on salary, approval rates, and more.

Key Statistics Comparison

Total H1B Filings
59
Institute for Cancer Research
+99.0%
5,960
Mastech
Median Salary
$74,008
Institute for Cancer Research
+21.2%
$93,933
Mastech
Approval Rate
100.0%
Institute for Cancer Research
100.0%
Mastech
Years Sponsoring
+11.1%
10
Institute for Cancer Research
9
Mastech

Historical Trends

H1B Filings Over Time

Institute for Cancer Research
Mastech
2009 2012 2015 2018 2021 2025 1 706 1,410

Median Salary Trend

Institute for Cancer Research
Mastech
2009 2012 2015 2018 2021 2025 $39k $72k $106k

Where & What They Hire

Top H1B Job Categories

Institute for Cancer Research
Medical Scientists, Except Epidemiologists 2 filings
Molecular and Cellular Biologists 1 filings
Mastech
15-1131 1 filings

Top H1B Work Locations

Institute for Cancer Research
Philadelphia, PA 3 filings
Mastech
San Jose, CA 1 filings

Year-by-Year Breakdown

Year Institute for Cancer Research Mastech
Filings Salary Approval Filings Salary Approval
FY2025 3 $74,008 100.0% - - -
FY2024 2 $53,216 100.0% - - -
FY2023 1 $65,270 100.0% - - -
FY2022 1 $55,307 - - - -
FY2021 6 $70,746 100.0% - - -
FY2020 2 $55,461 100.0% - - -
FY2019 13 $50,017 100.0% - - -
FY2018 13 $52,143 92.3% - - -
FY2017 13 $47,844 100.0% 1 $93,933 100.0%
FY2016 5 $42,840 100.0% 1,282 $95,328 99.7%
Showing most recent 10 years of 17 total

Frequently Asked Questions

Which company pays higher H1B salaries, Institute for Cancer Research or Mastech?
Mastech pays higher H1B salaries with a median of $93,933 compared to Institute for Cancer Research's $74,008.
Which company sponsors more H1B visas, Institute for Cancer Research or Mastech?
Mastech has sponsored more H1B visas with 5,960 total filings compared to Institute for Cancer Research's 59.
How do Institute for Cancer Research and Mastech H1B approval rates compare?
Institute for Cancer Research has a 100.0% H1B approval rate while Mastech has 100.0%. Both companies have the same approval rate.

View Full Details